Loading...
•
Jun 30, 2022
Allscripts Q2 2022 Earnings Report
Allscripts reported a consolidated revenue increase, driven by growth in Veradigm revenue and improved profitability, while also completing the sale of its Hospital and Large Physician Practices Segment.
Key Takeaways
Allscripts reported second quarter results with year-over-year growth in revenue, gross profit, and Adjusted EBITDA. The company completed the sale of its Hospital and Large Physician Practices Segment. Consolidated GAAP net loss totaled $64 million, while non-GAAP net income was $22 million.
Second quarter bookings of $107 million and $172 million year-to-date, up 10% from the first half of 2021
Veradigm revenue was $145 million compared with $133 million in the second quarter of 2021
Consolidated Allscripts revenue was $151 million compared with $141 million in the second quarter of 2021
Generated $42 million of cash flow from continuing operations in the quarter
Forward Guidance
Allscripts is affirming its prior annual outlook and currently expects to achieve:
Positive Outlook
- Veradigm revenue growth year-over-year between 6% to 7%
- Veradigm Adjusted EBITDA growth year-over-year between 10% to 15%
- Free cash flow from continuing operations between $110 million to $120 million
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...